Frontlight ResearchEarly access
WithdrawnNo phase
Maximizing Benefit of Lung Cancer Screening Incidental Findings of Cardiovascular, Respiratory and Breast Measures
Key facts
- Who runs it
- University of Montana
- Trial code
- Status
- Withdrawn
- Started
- Dec 2024
- Expected to end
- Mar 2029
- Type of study
- Interventional
- Treatments tested
- System implementation of patient-centered incidental findings report
- Record updated
- 9 December 2024
- Why it stopped
- Not funded by AHRQ
Who can take part
- Age
- 55 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Eligible for lung cancer screening program
- Presence of one of three incidental findings on low dose CT: coronary artery calcification, extensive breast density (for females), or emphysema
Who cannot take part
- No incidental findings from lung cancer screening low dose CT
About the trial
What the trial wants to find out
The investigators will implement a patient-centered outcomes tool for participants in lung cancer screening programs that receive clinically important incidental findings relevant to heart, breast and lung health. The study objective is to evaluate participant response and clinical follow-up following implementation of a patient-centered incidental findings communication tool.
The group in the trial
- ImplementationTreatment being tested
New lung cancer screening participants with clinically significant incidental findings received new patient-centered report
Treatment: System implementation of patient-centered incidental findings report
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 9 December 2024